The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial
Article in Nature Communications (March 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Article in Nature Communications (March 2024)
Article in International Journal of Molecular Sciences (January 2024)
Article in Clinical Cancer Research (June 2023)